Schedule 13D ownership disclosure
Amneal Pharmaceuticals Inc
Security class unavailable · CUSIP: 03168L105
Event date: 2022-12-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,328,767
- Percent of class
- 8.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-22-012413
- Form type
- SC 13D
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Dec 14, 2022
- Reporting period
- Dec 12, 2022
- Description
- Schedule 13D beneficial ownership